Survival benefit in women withBRCA1mutation or familial risk in the MRI screening study (MRISC)-Reference-Cited by-同舟云学术

Survival benefit in women withBRCA1mutation or familial risk in the MRI screening study (MRISC)

Published:2015-04-17 Issue:7 Volume:137 Page:1729-1738
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Saadatmand Sepideh¹,Obdeijn Inge-Marie²,Rutgers Emiel J.³,Oosterwijk Jan C.⁴,Tollenaar Rob A.⁵,Woldringh Gwendolyn H.⁶,Bergers Elisabeth⁷,Verhoef Cornelis¹,Heijnsdijk Eveline A.⁸,Hooning Maartje J.⁹,de Koning Harry J.⁸,Tilanus-Linthorst Madeleine M.¹

Affiliation:

1. Department of Surgery; Erasmus Medical Center-Cancer Institute; Rotterdam The Netherlands

2. Department of Radiology; Erasmus Medical Center; Rotterdam The Netherlands

3. Department of Surgery; the Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital; Amsterdam The Netherlands

4. Department of Genetics; University Medical Center, Groningen University; Groningen The Netherlands

5. Department of Surgery; Leiden University Medical Center; Leiden The Netherlands

6. Department of Human Genetics; Radboud University Medical Center; Nijmegen The Netherlands

7. Department of Radiology; VU University Medical Center; Amsterdam The Netherlands

8. Department of Public Health; Erasmus Medical Center; Rotterdam The Netherlands

9. Department of Medical Oncology; Erasmus Medical Center-Cancer Institute; Rotterdam The Netherlands

Funder

ZonMw, The Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.29534/fullpdf

Reference34 articles.

1. National Borstkanker Overleg Nederland (NABON) 2012 http://oncoline.nl/richtlijn/doc/index.php?type=pda&richtlijn_id=828

2. National Comprehensive Cancer Network (NCCN) http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf

3. National Institute for Health and Clinical Excellence guidelines (NICE) http://www.nice.org.uk/guidance/cg164/resources/guidance-familial-breast-cancer-pdf

4. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition;Kriege;N Engl J Med,2004

5. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results;Kuhl;Radiology,2000

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auditing Abbreviated Breast MR Imaging;Radiologic Clinics of North America;2024-07

2. Optimising the diagnostic accuracy of First post-contrAst SubtracTed breast MRI (FAST MRI) through interpretation-training: a multicentre e-learning study, mapping the learning curve of NHS Breast Screening Programme (NHSBSP) mammogram readers using an enriched dataset;Breast Cancer Research;2024-05-28

3. MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations;JAMA Oncology;2024-04-01

4. Optimising the diagnostic accuracy of First post-contrAst SubtracTed breast MRI (FAST MRI) through interpretation-training: a multicentre e-learning study, mapping the learning curve of NHS Breast Screening Programme (NHSBSP) mammogram readers using an enriched dataset;2024-01-25

5. Occurrence of malignancies other than breast and ovarian cancer in female carriers of a BRCA1/2 germline pathogenic variant;2024-01-08